Kadmon
$4.859876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$4.85
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.33 (+7.30%) Today
-$0.00 (-0.00%) As of 8:00 PM EST after-hours
Why Robinhood?
You can buy or sell Kadmon and other stocks, options, ETFs, and crypto commission-free!
About KDMN
Kadmon Holdings, Inc., also called Kadmon, is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics. It focuses on the treatment of autoimmune, inflammatory, and fibrotic diseases. Read More Its products include Ribasphere, RibaPak, Tetrabenazine, Valganciclovir, Abacavir, Entecavir, Lamivudine, and Zidovudine. The company was founded by Steven N. Gordon in September 2010 and is headquartered in New York, NY.
Employees
116
Headquarters
New York, New York
Founded
2010
Market Cap
721.35M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.56M
High Today
$4.85
Low Today
$4.59
Open Price
$4.63
Volume
1.91M
52 Week High
$5.38
52 Week Low
$1.63
Collections
KDMN Earnings
-$0.49
-$0.30
-$0.12
$0.07
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Mar 5, After Hours
People Also Bought
Viking Therapeutics
38,277
$6.65
-1.19%Amarin
16,082
$18.25
+3.58%Editas Medicine
9,963
$26.91
+0.34%Sorrento Therapeutics
12,022
$2.64
-2.94%Catalyst Pharmaceuticals
48,942
$5.25
+10.06%NIO
130,739
$3.91
+3.71%TG Therapeutics
5,270
$15.86
+0.51%Myovant Sciences
5,704
$11.38
-2.82%CRISPR
26,685
$55.75
-0.09%Geron
31,598
$1.31
+1.55%Verastem
17,386
$2.03
+1.50%Global Blood Therapeutics
1,150